Lehman David Aaron's Form 4 filing
Pulmonx Corp (LUNG) · filed Sep 5, 2024
- Accession no.
- 0001415889-24-022971
- Filed
- Sep 5, 2024
- Trade date
- Sep 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $38.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lehman David AaronCIK 0001354228 | Officer (GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | Common Stock | SSaleDisposed | −429 | $6.71 | −$2,878.59 | 208,684 | Direct | |
| Sep 3, 2024 | Common Stock | SSaleDisposed | −758 | $6.69 | −$5,071.02 | 207,926 | Direct | |
| Sep 3, 2024 | Common Stock | SSaleDisposed | −2,890 | $6.69 | −$19,334.1 | 205,036 | Direct | |
| Sep 3, 2024 | Common Stock | SSaleDisposed | −1,688 | $6.69 | −$11,292.72 | 203,348 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.